The US should have 100 million doses of one candidate coronavirus vaccine by the end of the year, Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID) and a member of the White House coronavirus task force, said Tuesday.
“Then, by the beginning of 2021, we hope to have a couple hundred million doses,” Fauci said during a live question and answer session with the Journal of the American Medical Association.
Fauci said the first vaccine candidate, made by biotech company Moderna in partnership with NIAID, should go into a final stage of trials in volunteers, known in the industry as Phase III, by mid-summer. Preparations at national and international sites are already under way, he said.
“The real business end of this all will be the Phase III that starts in the first week of July, hopefully, “ Fauci said. “We want to get as many datapoints as we can.”
Phase III will involve about 30,000 people. The vaccine will be tested in people between the ages of 18 and 55, as well as in the elderly and in people who have underlying health conditions.
“It’s going to be the entire spectrum,” Fauci said.
Fauci said Phase II of the trial started a few days ago. A few hundred volunteers will be involved in that part of the trial.